Alterations in brain structure related to breast cancer and its treatment: Chemotherapy and other considerations

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 374-387

  McDonald, Brenna C ^a   Saykin, Andrew J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IU Center for Neuroimaging   (United States)

Author keywords

Brain; Breast cancer; Chemotherapy; Frontal lobes; Magnetic resonance imaging; Neuroimaging; Voxel basedmorphometry

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT;

BRAIN REGION; BRAIN SIZE; BREAST CANCER; CANCER PATIENT; COGNITION; FRONTAL CORTEX; GRAY MATTER; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TEMPORAL CORTEX; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ANTINEOPLASTIC AGENTS; BRAIN; BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84901352376     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9256-x     Document Type: Review

References (62)

1. Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer-and cancer treatment-associated cognitive change: an update on the state of the science. Journal of Clinical Oncology, 30(30), 3675-3686.
2. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192-201.
3. Ashburner, J., & Friston, K. J. (2000). Voxel-based morphometry-the methods. NeuroImage, 11(6 Pt 1), 805-821.
4. Ashburner, J., & Friston, K. J. (2001). Why voxel-based morphometry should be used. NeuroImage, 14(6), 1238-1243.
5. Bassett, D. S., & Bullmore, E. (2006). Small-world brain networks. The Neuroscientist, 12(6), 512-523.
6. Bergouignan, L., Lefranc, J. P., Chupin, M., Morel, N., Spano, J. P., & Fossati, P. (2011). Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS ONE [Electronic Resource], 6(10), e25349.
7. Brown, M. S., Simon, J. H., Stemmer, S. M., Stears, J. C., Scherzinger, A., Cagnoni, P. J., et al. (1995). MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. Ajnr: American Journal of Neuroradiology, 16(10), 2013-2020.
8. Brown, M. S., Stemmer, S. M., Simon, J. H., Stears, J. C., Jones, R. B., Cagnoni, P. J., et al. (1998). White matter disease induced by highdose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. Ajnr: American Journal of Neuroradiology, 19(2), 217-221.
9. Carey, M. E., Haut, M.W., Reminger, S. L., Hutter, J. J., Theilmann, R., & Kaemingk, K. L. (2008). Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study. Ajnr: American Journal of Neuroradiology, 29(4), 792-797.
10. Ciesielski, K. T., Lesnik, P. G., Benzel, E. C., Hart, B. L., & Sanders, J. A. (1999). MRI morphometry of mamillary bodies, caudate nuclei, and prefrontal cortices after chemotherapy for childhood leukemia: multivariate models of early and late developing memory subsystems. Behavioral Neuroscience, 113(3), 439-450.
11. Conroy, S. K., McDonald, B. C., Ahles, T. A., West, J. D., &Saykin, A. J. (2013a). Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates. Brain Imaging and Behavior, epub ahead of print.
12. Conroy, S. K., McDonald, B. C., Smith, D. J., Moser, L. R., West, J. D., Kamendulis, L.M., et al. (2013b). Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research & Treatment, 137(2), 493-502.
13. Dale, A. M., Fischl, B., & Sereno, M. I. (1999). Cortical Surface-Based Analysis: I. Segmentation and Surface Reconstruction. NeuroImage, 9(2), 179-194.
14. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., et al. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Human Brain Mapping, 33(12), 2971-2983.
15. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S. A. M., Nederveen, A. J., et al. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32, 1206-1219.
16. de Ruiter, M. B., & Schagen, S. B. (2013). Functional MRI studies in non-CNS cancers. Brain Imaging and Behavior, epub ahead of print.
17. Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology, 30(3), 274-281.
18. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32(3), 480-493.
19. Deprez, S., Billiet, T., Sunaert, S., & Leemans, A. (2013). Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review. Brain Imaging and Behavior, epub ahead of print.
20. Eberling, J. L., Wu, C., Tong-Turnbeaugh, R., & Jagust, W. J. (2004). Estrogen-and tamoxifen-associated effects on brain structure and function. NeuroImage, 21(1), 364-371.
21. Eichbaum, M. H. R., Schneeweiss, A., & Sohn, C. (2007). Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 110(1), 224-225. author reply 225.
22. Fischl, B., Sereno, M. I., & Dale, A. M. (1999). Cortical surface-based analysis: II: Inflation, flattening, and a surface-based coordinate system. NeuroImage, 9(2), 195-207.
23. Glass, J. O., Reddick, W. E., Li, C.-S., Laningham, F. H., Helton, K. J., & Pui, C.-H. (2006). Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate. Magnetic Resonance Imaging, 24(6), 785-791.
24. Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., & Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage, 14(1 Pt 1), 21-36.
25. Gunning-Dixon, F. M., Brickman, A. M., Cheng, J. C., & Alexopoulos, G. S. (2009). Aging of cerebral white matter: a review of MRI findings. International Journal of Geriatric Psychiatry, 24(2), 109-117.
26. Hakamata, Y., Matsuoka, Y., Inagaki, M., Nagamine, M., Hara, E., Imoto, S., et al. (2007). Structure of orbitofrontal cortex and its longitudinal course in cancer-related post-traumatic stress disorder. Neuroscience Research, 59(4), 383-389.
27. Hara, E., Matsuoka, Y., Hakamata, Y., Nagamine, M., Inagaki, M., Imoto, S., et al. (2008). Hippocampal and amygdalar volumes in breast cancer survivors with posttraumatic stress disorder. Journal of Neuropsychiatry and Clinical Neurosciences, 20(3), 302-308.
28. Hofman, A., Breteler, M. M. B., van Duijn, C. M., Janssen, H. L. A., Krestin, G. P., Kuipers, E. J., et al. (2009). The Rotterdam Study: 2010 objectives and design update. European Journal of Epidemiology, 24(9), 553-572.
29. Hosseini, S. M. H., Koovakkattu, D., & Kesler, S. R. (2012). Altered small-world properties of gray matter networks in breast cancer. BMC Neurology, 12, 28.
30. Inagaki, M., Matsuoka, Y., Sugahara, Y., Nakano, T., Akechi, T., Fujimori, M., et al. (2004). Hippocampal volume and first major depressive episode after cancer diagnosis in breast cancer survivors. American Journal of Psychiatry, 161(12), 2263-2270.
31. Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109(1), 146-156.
32. Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., et al. (2013). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavior, and Immunity, 30(Supplement), S109-S116.
33. Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic breast cancer. Clinical Cancer Research, 15(21), 6665-6673.
34. Kesler, S. R., Kent, J. S., & O'Hara, R. (2011). Prefrontal cortex and executive function impairments in primary breast cancer. Archives of Neurology, 68(11), 1447-1453.
35. Kesler, S. R., Tanaka, H., & Koovakkattu, D. (2010). Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia. Brain Imaging and Behavior, 4(3-4), 256-269.
36. Koppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012a). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30(10), 1080-1086.
37. Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., et al. (2012b). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Research & Treatment, 132(3), 1099-1106.
38. Lesnik, P. G., Ciesielski, K. T., Hart, B. L., Benzel, E. C., & Sanders, J. A. (1998). Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model. Archives of Neurology, 55(12), 1561-1568.
39. Mandelblatt, J. S., Hurria, A., McDonald, B. C., Saykin, A. J., Stern, R. A., VanMeter, J.W., et al. (2013). Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Seminars in Oncology. in press.
40. Matsuoka, Y., Nagamine, M., Inagaki, M., Yoshikawa, E., Nakano, T., Akechi, T., et al. (2006). Cavum septi pellucidi and intrusive recollections in cancer survivors. Neuroscience Research, 56(3), 344-346.
41. Matsuoka, Y., Yamawaki, S., Inagaki, M., Akechi, T., & Uchitomi, Y. (2003). A volumetric study of amygdala in cancer survivors with intrusive recollections. Biological Psychiatry, 54(7), 736-743.
42. McDonald, B. C., Conroy, S.K., Ahles, T. A., West, J. D., &Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research & Treatment, 123(3), 819-828.
43. McDonald, B. C., Conroy, S.K., Ahles, T. A., West, J. D., &Saykin, A. J. (2012). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. Journal of Clinical Oncology, 30(20), 2500-2508.
44. McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2013). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain, Behavior, and Immunity, 30(Supplement), S115-S125.
45. Mechelli, A., Price, C. J., Friston, K. J., & Ashburner, J. (2005). Voxelbased morphometry of the human brain: methods and applications. Current Medical Imaging Reviews, 1(2), 105-113.
46. Nakano, T., Wenner, M., Inagaki, M., Kugaya, A., Akechi, T., Matsuoka, Y., et al. (2002). Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors. American Journal of Psychiatry, 159(12), 2087-2093.
47. Peelle, J. E., Cusack, R., & Henson, R. N. A. (2012). Adjusting for global effects in voxel-based morphometry: gray matter decline in normal aging. NeuroImage, 60(2), 1503-1516.
48. Petrella, J. R. (2011). Use of graph theory to evaluate brain networks: a clinical tool for a small world? Radiology, 259(2), 317-320.
49. Pomykala, K. L., de Ruiter, M. B., Deprez, S., McDonald, B. C., & Silverman, D. H. S. (2013). Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging and Behavior, epub ahead of print.
50. Radua, J., Canales-Rodríguez, E. J., Pomarol-Clotet, E., & Salvador, R. (2013). Validity of modulation and optimal settings for advanced voxel-based morphometry. Neuroimage, epub ahead of print.
51. Reddick, W. E., Shan, Z. Y., Glass, J. O., Helton, S., Xiong, X., Wu, S., et al. (2006). Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer, 106(4), 941-949.
52. Risacher, S. L., Saykin, A. J., West, J. D., Shen, L., Firpi, H. A., McDonald, B. C., et al. (2009). Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Current Alzheimer Research, 6(4), 347-361.
53. Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., et al. (2010). Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiology of Aging, 31(8), 1401-1418.
54. Saykin, A. J., Ahles, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8(4), 201-216.
55. Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuospatial workingmemory in breast cancer patients compared to controls: an FMRI study. Frontiers in Human Neuroscience, 5, 122.
56. Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. (2012a). Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. Journal of Clinical and Experimental Neuropsychology, 34(5), 543-560.
57. Scherling, C., Collins, B., MacKenzie, J., Lepage, C., Bielajew, C., & Smith, A. (2012b). Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. International Journal of Biology, 4(2), 3-25.
58. Silverman, D. H., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., et al. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103(3), 303-311.
59. Sporns, O., Chialvo, D. R., Kaiser, M., & Hilgetag, C. C. (2004). Organization, development and function of complex brain networks. Trends in Cognitive Sciences, 8(9), 418-425.
60. Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., & Simon, J. H. (1994). White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bonemarrow support. Ajnr: American Journal of Neuroradiology, 15(7), 1267-1273.
61. Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., et al. (2005). No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Research & Treatment, 92(1), 81-84.
62. Yoshikawa, E., Matsuoka, Y., Yamasue, H., Inagaki, M., Nakano, T., Akechi, T., et al. (2006). Prefrontal cortex and amygdala volume in first minor or major depressive episode after cancer diagnosis. Biological Psychiatry, 59(8), 707-712.